ISIN | LU0344046403 |
---|---|
Valor Number | 3744178 |
Bloomberg Global ID | |
Fund Name | Candriam Equities L Europe Innovation V-Acc |
Fund Provider |
CANDRIAM
Serenity, Bloc - B, 19-21, route d'Arlon 8009 Strassen E-Mail: CH@Candriam.com Phone: + 352 2797-1 Web: https://www.candriam.com |
Fund Provider | CANDRIAM |
Representative in Switzerland |
CACEIS (Switzerland) SA Nyon Phone: +41 22 360 94 00 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in equities of companies showing evidence of strong and successful innovative capabilities which have their registered office and/or carry out the bulk of their business activities in Europe, and to outperform the benchmark index. |
Peculiarities |
Current Price * | 1,675.25 EUR | 17.04.2025 |
---|---|---|
Previous Price * | 1,686.44 EUR | 16.04.2025 |
52 Week High * | 1,923.93 EUR | 17.02.2025 |
52 Week Low * | 1,585.13 EUR | 09.04.2025 |
NAV * | 1,675.25 EUR | 17.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 496,217,550 | |
Unit/Share Assets *** | 390,529 | |
Trading Information SIX |
YTD Performance | -3.28% |
30.12.2024 - 17.04.2025
30.12.2024 17.04.2025 |
---|---|---|
YTD Performance (in CHF) | -4.27% |
30.12.2024 - 17.04.2025
30.12.2024 17.04.2025 |
1 month | -9.75% |
17.03.2025 - 17.04.2025
17.03.2025 17.04.2025 |
3 months | -6.51% |
17.01.2025 - 17.04.2025
17.01.2025 17.04.2025 |
6 months | -8.28% |
17.10.2024 - 17.04.2025
17.10.2024 17.04.2025 |
1 year | -6.29% |
17.04.2024 - 17.04.2025
17.04.2024 17.04.2025 |
2 years | -6.32% |
17.04.2023 - 17.04.2025
17.04.2023 17.04.2025 |
3 years | -9.51% |
19.04.2022 - 17.04.2025
19.04.2022 17.04.2025 |
5 years | +24.99% |
17.04.2020 - 17.04.2025
17.04.2020 17.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
BioMerieux SA | 6.08% | |
---|---|---|
Kerry Group PLC Class A | 5.80% | |
Nestle SA | 5.39% | |
Dassault Systemes SE | 4.94% | |
DSM Firmenich AG | 4.80% | |
Hexagon AB Class B | 4.72% | |
Halma PLC | 4.47% | |
ASML Holding NV | 3.79% | |
Spirax Group PLC | 3.07% | |
Carl Zeiss Meditec AG | 2.76% | |
Last data update | 31.03.2025 |
TER *** | 0.56% |
---|---|
TER date *** | 30.06.2024 |
Performance Fee *** | 20.00% |
PTR | |
Max. Management Fee *** | 0.45% |
Ongoing Charges *** | 0.56% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |